Novo Nordisk
NVO
#104
Rank
HK$1.274 T
Marketcap
HK$284.82
Share price
0.19%
Change (1 day)
-49.43%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2025 (TTM): HK$163.51 Billion

According to Novo Nordisk's latest financial reports the company's current earnings are HK$47.70 Billion. , an increase over its 2024 earnings that were of HK$154.31 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2025

Annual earnings

Year Earnings Change
2025 HK$164.01 B6.28%
2024 HK$154.31 B28.01%
2023 HK$120.55 B57.81%
2022 HK$76.39 B5.24%
2021 HK$72.59 B12.38%
2020 HK$64.59 B13.11%
2019 HK$57.10 B-3.45%
2018 HK$59.14 B1.88%
2017 HK$58.05 B4.3%
2016 HK$55.65 B10.32%
2015 HK$50.45 B7.47%
2014 HK$46.94 B3.4%
2013 HK$45.40 B19.09%
2012 HK$38.12 B15.58%
2011 HK$32.98 B16.58%
2010 HK$28.29 B25.66%
2009 HK$22.51 B10.68%
2008 HK$20.34 B55.82%
2007 HK$13.05 B7.02%
2006 HK$12.20 B19.05%
2005 HK$10.24 B10.55%
2004 HK$9.27 B
2002 HK$6.37 B-14.39%
2001 HK$7.44 B-52.82%
2000 HK$15.78 B250%
1999 HK$4.50 B31.21%
1998 HK$3.43 B34.31%
1997 HK$2.55 B11.46%
1996 HK$2.29 B9.03%
1995 HK$2.10 B-3.15%
1994 HK$2.17 B-0.67%
1993 HK$2.18 B45.38%
1992 HK$1.50 B-13.81%
1991 HK$1.74 B37.12%
1990 HK$1.27 B-0.79%
1989 HK$1.28 B26.2%
1988 HK$1.01 B24.97%
1987 HK$0.81 B-0.9%
1986 HK$0.82 B-7.78%
1985 HK$0.89 B24.87%
1984 HK$0.71 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$79.74 B-51.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$201.33 B 22.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$60.24 B-63.27%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$72.98 B-55.50%๐Ÿ‡บ๐Ÿ‡ธ USA